Data / Form D filings / Evozyne, Inc.
Evozyne, Inc.: Form D filings
Evozyne, Inc., a biotechnology company in Chicago, IL, filed 3 Form D notices with the SEC between 2020 and 2023. The latest, on September 29, 2023, reports $81 million sold of a $100 million offering to 29 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 330 N. WABASH AVENUE, SUITE 3500, Chicago, IL, 60611
- Phone
- (312) 847-1322
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2019
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1811288
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Sep 29, 2023 | New notice | $100,000,001 | $81,000,122 | $18,999,879 | 29 | Sep 14, 2023 | sec.gov |
| Apr 22, 2021 | New notice | $59,183,711 | $54,183,709 | $5,000,002 | 12 | Apr 9, 2021 | sec.gov |
| May 7, 2020 | New notice | $9,183,673 | $9,183,673 | 2 | Apr 27, 2020 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Antonio S. Gracias | Director | |
| Jeffrey S. Aronin | Executive Officer, Director | |
| Aris J. Theologis | Executive Officer | |
| Darien S. Parhad | Executive Officer | |
| Jude M. Sullivan | Executive Officer | |
| Aleina M. Lee | Executive Officer | |
| Rama J. Ranganathan | Executive Officer, Director | |
| Patrick J. Morris | Executive Officer, Director | |
| Mike S. Gamson | Executive Officer, Director | |
| Matthew M. Rizzo | Director | |
| Arjun S. Rallapalli | Executive Officer |
Other biotechnology companies in Illinois that filed recently
- Neopenda, PBC $215,000 · Aug 27, 2026
- Auvi Labs, Inc. $442,352 · Aug 26, 2026
- Archean Sciences, Inc. $385,000 · Aug 13, 2026
Every Form D from the week of Sep 25, 2023 · All recent filings in Illinois · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Evozyne, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.